Articles dans des revues avec comité de lecture (56)
  1. 1. Ehongo Bidime, A., Dugauquier, A., Kisma, N., De Maertelaer, V., Nana Wandji, B., Tchatchou Tomy, W., Alaoui Mhammedi, Y., Coppens, K., Leroy, K., & Bremer, F. (2023). Myopic (Peri)papillary Changes and Visual Field Defects. Clinical Ophthalmology (Print), 17, 3295-3306. doi:10.2147/OPTH.S404167
  2. 2. Ehongo Bidime, A., Hasnaoui, Z., Kisma, N., Alaoui Mhammedi, Y., Dugauquier, A., Coppens, K., Wellens, E., de Maertelaere, V., Bremer, F., & Leroy, K. (2023). Peripapillary intrachoroidal cavitation at the crossroads of peripapillary myopic changes. International journal of ophthalmology, 16(12), 2063-2070. doi:10.18240/ijo.2023.12.20
  3. 3. Ando, K., Nagaraj, S., Küçükali, F., De Fisenne, M.-A., Kosa, A.-C., Doeraene, E., López Gutiérrez, L., Brion, J. P., & Leroy, K. (2022). PICALM and Alzheimer’s Disease: An Update and Perspectives. Cells, 11(24), 3994. doi:10.3390/cells11243994
  4. 4. De Fisenne, M.-A., Yilmaz, Z., De Decker, R., Suain, V., Buée, L., Ando, K., Brion, J. P., & Leroy, K. (2022). Alzheimer PHF-tau aggregates do not spread tau pathology to the brain via the Retino-tectal projection after intraocular injection in male mouse models. Neurobiology of disease, 174, 105875. doi:10.1016/j.nbd.2022.105875
  5. 5. Ehongo Bidime, A., Bacq, N., Kisma, N., Dugauquier, A., Alaoui Mhammedi, Y., Coppens, K., Bremer, F., & Leroy, K. (2022). Analysis of Peripapillary Intrachoroidal Cavitation and Myopic Peripapillary Distortions in Polar Regions by Optical Coherence Tomography. Clinical Ophthalmology (Print), Volume 16, 2617-2629. doi:10.2147/OPTH.S376597
  6. 6. Chivasso, C., Nesverova, V., Jarva, M., Blanchard, A., Rose, K. L., Oberg, K., Wang, Z., Martin, M., Lhotellerie, F., Zindy, E., Junqueira, B., Leroy, K., Vanhollebeke, B., Delforge, V., Bolaky, N., Perret, J., Soyfoo, M. S., Moscato, S., Baldini, C., Chaumont, F., Mattii, L., Schey, K. L., Myal, Y., Törnroth-Horsefield, S., & Delporte, C. (2021). Unraveling Human AQP5-PIP Molecular Interaction and Effect on AQP5 Salivary Glands Localization in SS Patients. Cells, 10, 2108.
  7. 7. Sáez-Orellana, F., Leroy, T., Ribeiro, F., Kreisler, A., Leroy, K., Lalloyer, F., Baugé, E., Staels, B., Duyckaerts, C., Brion, J. P., Gailly, P., Octave, J. N., & Pierrot, N. (2021). Regulation of PPARα by APP in Alzheimer disease affects the pharmacological modulation of synaptic activity. JCI insight, 6(16). doi:10.1172/jci.insight.150099
  8. 8. Ando, K., Erneux, C., Homa, M., Houben, S., De Fisenne, M.-A., Brion, J. P., & Leroy, K. (2021). Dysregulation of Phosphoinositide 5-Phosphatases and Phosphoinositides in Alzheimer's Disease. Frontiers in Neuroscience, 15, 614855. doi:10.3389/fnins.2021.614855
  9. 9. Houben, S., Homa, M., Yilmaz, Z., Leroy, K., Brion, J. P., & Ando, K. (2021). Tau Pathology and Adult Hippocampal Neurogenesis: What Tau Mouse Models Tell us? Frontiers in neurology, 12, 610330. doi:10.3389/fneur.2021.610330
  10. 10. Ando, K., Ndjim, M., Turbant, S., Fontaine, G., Pregoni, G., Dauphinot, L., Yilmaz, Z., Suain, V., Mansour, S., Authelet, M., De Dekker, R., Leroy, K., Delatour, B., Letournel, F., Martin-Négrier, M.-L., Chapon, F., Godfraind, C., Maurage, C.-A., Deramecourt, V., Meyronnet, D., Streichenberger, N., De Paula Rosa Passetti, A. P., Rigau, V., & Burel-Vandenbos, F. (2020). The lipid phosphatase Synaptojanin 1 undergoes a significant alteration in expression and solubility and is associated with brain lesions in Alzheimer’s disease. Acta neuropathologica communications, 8(1). doi:10.1186/s40478-020-00954-1
  11. 11. Houben, S., De Fisenne, M.-A., Ando, K., Vanden Dries, V., Poncelet, L., Yilmaz, Z., Mansour, S., De Decker, R., Brion, J. P., & Leroy, K. (2020). Intravenous injection of PHF-Tau proteins from Alzheimer Brain exacerbates neuroinflammation, Amyloid beta, and tau pathologies in 5XFAD transgenic mice. Frontiers in Molecular Neuroscience, 13, 10.3389/fnmol.2020.00106, 106.
  12. 12. Ando, K., Ferlini, L., Suain, V., Yilmaz, Z., Mansour, S., Le Ber, I., Bouchard, C., Leroy, K., Durr, A., Clot, F., Sarazin, M., Bier, J. C., & Brion, J. P. (2020). de novo MAPT mutation G335A causes severe brain atrophy, 3R and 4R PHF-tau pathology and early onset frontotemporal dementia. Acta neuropathologica communications, 8(1), 94. doi:10.1186/s40478-020-00977-8
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 Suivant >>